SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-016268
Filing Date
2023-05-11
Accepted
2023-05-11 07:10:41
Documents
51
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 941909
2 ex10-1.htm EX-10.1 20760
3 ex31-1.htm EX-31.1 20236
4 ex31-2.htm EX-31.2 20321
5 ex32-1.htm EX-32.1 7790
6 ex32-2.htm EX-32.2 8123
  Complete submission text file 0001493152-23-016268.txt   3257304

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE indp-20230331.xsd EX-101.SCH 22277
8 XBRL CALCULATION FILE indp-20230331_cal.xml EX-101.CAL 39987
9 XBRL DEFINITION FILE indp-20230331_def.xml EX-101.DEF 65000
10 XBRL LABEL FILE indp-20230331_lab.xml EX-101.LAB 214095
11 XBRL PRESENTATION FILE indp-20230331_pre.xml EX-101.PRE 161689
45 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 268554
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 (646) 427-2727
Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40652 | Film No.: 23908779
SIC: 2834 Pharmaceutical Preparations